This mixed-methods study follows a prospective cohort of participants receiving Mifeprex®
(mifepristone) by a clinician in advance of a potential unintended pregnancy. Women
participating in this study will be assessed by a clinician and provided Mifeprex® and
misoprostol in a clinical setting. To assess acceptability of this service delivery model
among participants, and feasibility of implementing a larger randomized controlled trial, the
study will survey participants, evaluate any clinical outcomes recorded during clinical
visits, and interview participants about their experiences participating in the study.